Aggressive cutaneous T-cell lymphomas after TNFα blockade
- 31 October 2004
- journal article
- case report
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 51 (4), 660-662
- https://doi.org/10.1016/j.jaad.2004.03.047
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Role of Novel Biological Therapies in Psoriatic ArthritisBioDrugs, 2003
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002
- Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapyJournal of the American Academy of Dermatology, 2002
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentThe New England Journal of Medicine, 2001
- Inflammatory Skin Diseases, T Cells, and Immune SurveillanceThe New England Journal of Medicine, 1999
- Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5 and TRAF2 Are Involved in CD30-mediated NFκB ActivationOnline Journal of Public Health Informatics, 1997
- CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Cutaneous T-cell lymphoma associated with HIV infectionJournal of the American Academy of Dermatology, 1993
- Mycosis Fungoides of the Mastoid, Middle Ear, and CNSArchives of Dermatology, 1983